Key result
TRAP-induced platelet-neutrophil conjugate formation independently predicted in-hospital recurrent myocardial ischemia in ACS patients.
Why the study?
Does platelet-leukocyte conjugate formation predict in-hospital recurrent myocardial ischemia in patients with acute coronary syndromes?
Observational (n=30)
Does platelet-leukocyte conjugate formation predict in-hospital recurrent myocardial ischemia in patients with acute coronary syndromes?
Answers are grounded in this paper and cite their sources.
TRAP-induced platelet-neutrophil conjugate formation is an independent predictor of in-hospital recurrent myocardial ischemia in patients with acute coronary syndromes.
Platelet-leukocyte conjugates are increased in patients with coronary artery disease but the relationship between conjugate formation and myocardial ischemic outcome is unknown. We prospectively evaluated the relationship between conjugate formation and the development of recurrent myocardial ischemia in patients with acute coronary syndromes (ACS). Platelet-leukocyte conjugate formation (induced by thrombin receptor activating peptide (TRAP)) and platelet aggregation (induced by ADP and arachidonic acid) were assessed in 30 patients with unstable angina or non-ST elevation myocardial infarction. All patients were treated with beta-blockers, aspirin, heparin, and GPIIb-IIIa antagonists and were followed for in-hospital recurrent myocardial ischemia. Troponin I and C-reactive protein (CRP) were also measured. Seven patients (23%) experienced recurrent ischemia. Platelet-neutrophil conjugates were greater in ischemic patients (59 +/- 9 and 36 +/- 4%, P = 0.007, for + ischemia and -ischemia, respectively). Platelet aggregation did not differ between ischemic and nonischemic patients, and there was no significant relationship between aspirin resistance and ischemic outcome. Troponin I was greater in patients who developed recurrent ischemia (3.04 +/- 1.73 vs. 0.70 +/- 0.21 ng/ml, P = 0.03, for +ischemia and -ischemia, respectively) but CRP was not. TRAP-induced platelet-neutrophil conjugate formation was an independent predictor of ischemic outcome (OR 1.07, 95% CI 1.00-1.15, for each 1% increase in conjugate formation). Receiver operator characteristic analysis showed platelet-neutrophil conjugates to have good ability to discriminate between ischemic and nonischemic patients (AUC of 0.84, P < 0.05). TRAP induced platelet-neutrophil conjugate formation is related to in vivo ischemic risk in ACS patients.
No takes yet. Share an insight, caveat, or question.
Faraday et al. (2004) conducted an observational in acute coronary syndromes (n=30). Platelet-neutrophil conjugate formation was evaluated on recurrent myocardial ischemia (OR 1.07, 95% CI 1.00-1.15). TRAP-induced platelet-neutrophil conjugate formation independently predicted in-hospital recurrent myocardial ischemia in ACS patients.
Synapse has enriched 10 related papers. Consider them for comparative context: